Clínica Baviera, S.A.

MSE:CBAV.MC

36.9 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 65.12666.40861.33347.67456.52359.39453.74342.06950.24652.39147.84138.39845.29141.240.2232.79520.20229.40935.05227.22232.36129.69829.98323.14327.66828.527.51822.21225.33324.81724.42119.6323.22224.29924.67718.58820.48421.77823.38317.70319.78221.75320.96416.67518.09924.23832.92510.1722.624.186
Cost of Revenue 049.529000045.36835.56938.58937.362030.69633.89730.13531.29800000000000000000000000000000000000
Gross Profit 65.12616.87961.33347.67456.52359.3948.3756.511.65715.02947.8417.70211.39411.0658.92132.79520.20229.40935.05227.22232.36129.69829.98323.14327.66828.527.51822.21225.33324.81724.42119.6323.22224.29924.67718.58820.48421.77823.38317.70319.78221.75320.96416.67518.09924.23832.92510.1722.624.186
Gross Profit Ratio 10.25411110.1560.1550.2320.28710.2010.2520.2690.22211111111111111111111111111111111111
Reseach & Development Expenses 00000000000000000000000000000000000000000000000000
General & Administrative Expenses 00000000000000000000000000000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000000000000000000000000000
SG&A 00000000000000000000000000000000000000000000000000
Other Expenses 00000-47.78919.24348.48625.74137.36217.05641.67522.91830.13516.04532.20912.42626.18314.76831.97420.07724.43312.28227.66816.97722.54811.82426.14415.68821.2689.66424.50313.75420.2659.72324.16513.7719.739.75123.22213.87418.8219.72320.99611.35221.57623.80813.73916.60322.116
Operating Expenses 34.24349.52921.03954.31928.90843.54319.24348.48625.74137.36217.05641.67522.91830.13516.04532.20912.42626.18314.76831.97420.07724.43312.28227.66816.97722.54811.82426.14415.68821.2689.66424.50313.75420.2659.72324.16513.7719.739.75123.22213.87418.8219.72320.99611.35221.57623.80813.73916.60322.116
Operating Income 15.91316.87913.4047.44413.52611.6057.9826.49111.59715.0299.1977.70111.39511.0658.9216.7441.6173.2265.5842.4615.0855.2654.8541.7024.4685.9524.3642.4443.2683.552.9761.3413.2554.0343.3390.261.0542.0482.368-0.1750.5252.9322.158-1.0883.5142.662-3.6891.4950.9332.07
Operating Income Ratio 0.2440.2540.2190.1560.2390.1950.1490.1540.2310.2870.1920.2010.2520.2690.2220.2060.080.110.1590.090.1570.1770.1620.0740.1610.2090.1590.110.1290.1430.1220.0680.140.1660.1350.0140.0510.0940.101-0.010.0270.1350.103-0.0650.1940.11-0.1120.1470.0410.086
Total Other Income Expenses Net -0.196-0.103-0.279-0.04-0.1474.14-0.083-0.125-0.104-0.107-0.094-0.117-0.116-0.1310.086-0.11-0.14-0.158-0.141-0.157-0.184-0.124-0.02-0.052-0.057-0.039-0.038-0.053-0.048-0.06-0.042-0.068-0.06-0.093-0.0710.398-0.098-0.114-0.177-0.075-0.104-0.089-0.250.039-0.188-0.067-0.265-0.02-0.197-0.136
Income Before Tax 15.71716.77613.1257.40413.37915.7457.8996.36611.49314.9229.1027.58411.27910.9349.0076.6341.4773.0685.4432.3044.9015.1414.8331.654.4115.9134.3262.3913.223.492.9341.2733.1953.9413.2680.4930.9561.9342.192-0.250.4212.8431.908-1.0493.3262.595-3.9541.4750.7361.934
Income Before Tax Ratio 0.2410.2530.2140.1550.2370.2650.1470.1510.2290.2850.190.1980.2490.2650.2240.2020.0730.1040.1550.0850.1510.1730.1610.0710.1590.2070.1570.1080.1270.1410.120.0650.1380.1620.1320.0270.0470.0890.094-0.0140.0210.1310.091-0.0630.1840.107-0.120.1450.0330.08
Income Tax Expense 4.1644.3623.3081.9163.5554.141.921.7593.0393.8153.0362.0412.7853.1062.6161.9990.4970.9411.1850.8661.3521.4840.9840.6281.3291.9581.0120.8390.8140.8871.0930.4290.8551.0210.7580.2080.3150.5310.294-0.0710.1310.8570.6-0.3061.0040.779-0.4120.4430.2210.58
Net Income 11.01312.4149.0545.9299.38311.6055.3515.0188.04311.1075.5255.7868.2517.8286.24.660.9552.1274.1511.4843.5033.6573.7661.1242.9813.9553.2081.6392.322.6031.810.912.2742.922.5510.3290.5961.4041.958-0.1680.2791.9861.448-0.1411.7631.817-1.537-0.420.5721.354
Net Income Ratio 0.1690.1870.1480.1240.1660.1950.10.1190.160.2120.1150.1510.1820.190.1540.1420.0470.0720.1180.0550.1080.1230.1260.0490.1080.1390.1170.0740.0920.1050.0740.0460.0980.120.1030.0180.0290.0640.084-0.0090.0140.0910.069-0.0080.0970.075-0.047-0.0410.0250.056
EPS 0.680.760.490.290.460.710.370.120.20.680.340.340.510.480.380.290.0590.130.250.0910.210.220.230.0690.180.240.20.10.140.160.110.0560.140.180.160.020.0370.0860.12-0.010.0170.120.089-0.0090.110.11-0.094-0.0260.0320.083
EPS Diluted 0.680.760.490.290.460.710.370.120.20.680.340.340.510.480.380.290.0590.130.250.0910.210.220.230.0690.180.240.20.10.140.160.110.0560.140.180.160.020.0370.0860.12-0.010.0170.120.089-0.0090.110.11-0.094-0.0260.0320.083
EBITDA 20.96721.4518.02511.75817.65119.77111.83910.35915.29218.60612.79211.28214.83314.54512.55110.1214.9726.6229.0895.7628.3958.3626.1462.9345.6917.1635.5153.0834.5444.8794.2722.5444.4795.2195.0451.3432.2913.3273.6781.1031.7944.1183.2590.0624.4374.061-1.3422.12.393.581
EBITDA Ratio 0.3220.3230.2940.2470.3120.3330.220.2460.3040.3550.2670.2940.3280.3530.3120.3090.2460.2250.2590.2120.2590.2820.2050.1270.2060.2510.20.1390.1790.1970.1750.130.1930.2150.2040.0720.1120.1530.1570.0620.0910.1890.1550.0040.2450.168-0.0410.2060.1060.148